The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Aspirin Inhibits Nuclear Factor–κB Mobilization and Monocyte Adhesion in Stimulated Human Endothelial Cells
Abstract
Background The induction of vascular cell adhesion molecule–1 (VCAM-1) and E-selectin by tumor necrosis factor–α (TNF) is mediated by mobilization of the transcription factor nuclear factor–κB (NF-κB). Since salicylates have been reported to inhibit NF-κB activation by preventing the degradation of its inhibitor IκB, we studied a potential inhibition of this pathway by acetylsalicylate (aspirin) in human umbilical vein endothelial cells (HUVECs). Methods and Results Gel-shift analyses demonstrated dose-dependent inhibition of TNF-induced NF-κB mobilization by aspirin at concentrations ranging from 1 to 10 mmol/L. Induction of VCAM-1 and E-selectin surface expression by TNF was dose-dependently reduced by aspirin over the same range, while induction of intercellular adhesion molecule–1 (ICAM-1) was hardly affected. Aspirin appeared to prevent VCAM-1 transcription, since it dose-dependently inhibited induction of VCAM-1 mRNA by TNF. As a functional consequence, adhesion of U937 monocytes to TNF-stimulated HUVECs was markedly reduced by aspirin due to suppression of VCAM-1 and E-selectin upregulation. These effects of aspirin were not related to the inhibition of cyclooxygenase activity, since indomethacin was ineffective. Conclusions Our data suggest that aspirin inhibits NF-κB mobilization, induction of VCAM-1 and E-selectin, and subsequent monocyte adhesion in endothelial cells stimulated by TNF, thereby providing an additional mechanism for therapeutic effects of aspirin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
Schreck, R., Rieber, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,712
O'Brien, K. D., Allen, M. D., McDonald, T. O., Chait, A., Harlan, J. M., Fishbein, D., McCarty, J., Ferguson, M., Hudkins, K., & Benjamin, C. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116670 · Cited by 703
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.
Libby, P., & Hansson, G. K. (1991) · PubMed · Cited by 663
The inducible transcription factor NF-κ B: structure-function relationship of its protein subunits
Grimm, S., & Baeuerle, P. A. (1993) · Biochemical Journal · doi:10.1042/bj2900297 · Cited by 429
Functional analysis of the human vascular cell adhesion molecule 1 promoter.
Neish, A. S., Williams, A. J., Palmer, H. J., Whitley, M. Z., & Collins, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1583 · Cited by 424
Cited by
Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T., & Gerritsen, M. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21096 · Cited by 1,053
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
Tegeder, I., Pfeilschifter, J., & Geisslinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0390rev · Cited by 747
Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression
M. Joussen, A., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Döhmen, S., & P. Adamis, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0707fje · Cited by 567
Cell biology of tissue factor, the principal initiator of blood coagulation
Camerer, E., Kolstø, A.-B., & Prydz, H. (1996) · Thrombosis Research · doi:10.1016/0049-3848(95)00209-x · Cited by 408
Differential chemokine receptor expression and function in human monocyte subpopulations
Weber, C., Belge, K.-U., von Hundelshausen, P., Draude, G., Steppich, B., Mack, M., Frankenberger, M., Weber, K. S. C., & Ziegler-Heitbrock, H. W. L. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.5.699 · Cited by 402
Self-citationNuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target
Lee, J., & Burckart, G. J. (1998) · The Journal of Clinical Pharmacology · doi:10.1177/009127009803801101 · Cited by 365
Ollivier, V., Parry, G. C. N., Cobb, R. R., de Prost, D., & Mackman, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20828 · Cited by 336
Activation of the transcription factor nuclear factor‐κB in human inflamed synovial tissue
Marok, R., Winyard, P. G., Coumbe, A., Kus, M. L., Gaffney, K., Blades, S., Mapp, P. I., Morris, C. J., Blake, D. R., Kaltschmidt, C., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390407 · Cited by 316
Peter, K., Nawroth, P., Conradt, C., Nordt, T., Weiss, T., Boehme, M., Wunsch, A., Allenberg, J., Kübler, W., & Bode, C. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.3.505 · Cited by 306
ZHANG, W.-J., & FREI, B. (2001) · The FASEB Journal · doi:10.1096/fj.01-0260com · Cited by 300
Weber, K. S. C., Nelson, P. J., Gröne, H.-J., & Weber, C. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2085 · Cited by 279
Self-citationThe role of virgin olive oil components in the modulation of endothelial function
Perona, J. S., Cabello-Moruno, R., & Ruiz-Gutierrez, V. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.11.007 · Cited by 274
Rajesh, M., Mukhopadhyay, P., Bátkai, S., Haskó, G., Liaudet, L., Huffman, J. W., Csiszar, A., Ungvari, Z., Mackie, K., Chatterjee, S., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00688.2007 · Cited by 260
Aspirin as a Promising Agent for Decreasing Incidence of Cerebral Aneurysm Rupture
Hasan, D. M., Mahaney, K. B., Brown, R. D., Meissner, I., Piepgras, D. G., Huston, J., Capuano, A. W., Torner, J. C., & for the International Study of Unruptured Intracranial Aneurysms Investigators (2011) · Stroke · doi:10.1161/strokeaha.111.619411 · Cited by 259
An aging Interventions Testing Program: study design and interim report
Miller, R. A., Harrison, D. E., Astle, C. M., Floyd, R. A., Flurkey, K., Hensley, K. L., Javors, M. A., Leeuwenburgh, C., Nelson, J. F., Ongini, E., et al. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00311.x · Cited by 197
Design of aging intervention studies: the NIA interventions testing program
Nadon, N. L., Strong, R., Miller, R. A., Nelson, J., Javors, M., Sharp, Z. D., Peralba, J. M., & Harrison, D. E. (2008) · AGE · doi:10.1007/s11357-008-9048-1 · Cited by 142
Ruel, G., Pomerleau, S., Couture, P., Lemieux, S., Lamarche, B., & Couillard, C. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114507811986 · Cited by 96
Relevance of new drug discovery to reduce NF-κB activation in cardiovascular disease
Madonna, R., & De Caterina, R. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.005 · Cited by 46
Metadata
- Authors
- Weber, C., Erl, W., Pietsch, A., & Weber, P. C.
- Venue
- Circulation
- Published
- 1995-04
- Volume
- 91
- Issue
- 7
- Pages
- 1914-1917
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2089272736
- Cited by
- 257
- References
- 19
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.